id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-E-0464-0007,FDA,FDA-2004-E-0464,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2007-05-14T04:00:00Z,2007,5,,,2025-11-20T18:34:31Z,,0,0,0900006480475803
FDA-2004-E-0464-0006,FDA,FDA-2004-E-0464,Redetermination of Regulatory Review Period for Purposes of Patent Extension; BONIVA; Correction,Notice,Correction,2006-10-11T04:00:00Z,2006,10,2006-10-11T04:00:00Z,,2025-11-20T18:32:10Z,E6-16816,0,0,0900006480475801
FDA-2004-E-0464-0005,FDA,FDA-2004-E-0464,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2006-09-25T04:00:00Z,2006,9,,,2025-11-20T18:28:35Z,,0,0,09000064804757ff
FDA-2004-E-0464-0004,FDA,FDA-2004-E-0464,Determination of Regulatory Review Period for Purposes of Patent Extension; BONIVA,Notice,General Notice,2006-06-23T04:00:00Z,2006,6,2006-06-22T04:00:00Z,,2025-11-21T10:00:10Z,E6-9817,0,0,09000064804757e9
FDA-2004-E-0464-0003,FDA,FDA-2004-E-0464,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2006-05-24T04:00:00Z,2006,5,,,2025-11-20T18:23:01Z,,0,0,09000064804757e8
FDA-2004-E-0464-0002,FDA,FDA-2004-E-0464,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2004-10-22T04:00:00Z,2004,10,,,2025-11-20T18:21:13Z,,0,0,09000064804757e6
FDA-2004-E-0464-0001,FDA,FDA-2004-E-0464,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2004-09-28T04:00:00Z,2004,9,,,2025-11-20T18:19:14Z,,0,0,09000064804757ae